Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose

Archives of Biochemistry and Biophysics

Volumn 475, Issue 2, 2008, Pages 128-134

  Liu, Weihua ^a   Liu, Peiqinq ^a   Tao, Sha ^b   Deng, Yanhui ^a   Li, Xuejuan ^a   Lan, Tian ^a   Zhang, Xiaoyan ^a   Guo, Fenfen ^a   Huang, Wenge ^a   Chen, Fengying ^a   Huang, Heqing ^a   Zhou, Shu Feng ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

Author keywords

Aldose reductase; Berberine; Diabetic nephropathy; Oxidative stress; Polyol pathway

Indexed keywords

ALDEHYDE REDUCTASE; BERBERINE; CREATININE; GLUCOSE; MALONALDEHYDE; MESSENGER RNA; SUPEROXIDE; SUPEROXIDE DISMUTASE; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; KIDNEY INJURY; MALE; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; RAT; STREPTOZOCIN DIABETES; UREA NITROGEN BLOOD LEVEL;

ALDEHYDE REDUCTASE; ANIMALS; BERBERINE; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; FORMAZANS; GLUCOSE; MALE; MESANGIAL CELLS; MOLECULAR STRUCTURE; OXIDATIVE STRESS; RATS; RATS, WISTAR; TETRAZOLIUM SALTS;

RATTUS;

EID: 44949179681     PISSN: 00039861     EISSN: 10960384     Source Type: Journal    
DOI: 10.1016/j.abb.2008.04.022     Document Type: Article

References (41)

1. Kikkawa R., Koya D., and Haneda M. Am. J. Kidney Dis. 41 (2003) S19-S21
2. Raptis A.E., and Viberti G. Exp. Clin. Endocrinol. Diabetes 109 Suppl. 2 (2001) S424-S437
3. Schena F.P., and Gesualdo L. J. Am. Soc. Nephrol. 16 Suppl. 1 (2005) S30-S33
4. Ross W.R., and McGill J.B. Adv. Chronic Kidney Dis. 13 (2006) 325-335
5. Ichinose K., Kawasaki E., and Eguchi K. Am. J. Nephrol. 27 (2007) 554-564
6. Ruster C., and Wolf G. Front. Biosci. 3 (2008) 944-955
7. Umezono T., Toyoda M., Kato M., Miyauchi M., Kimura M., Maruyama M., Honma M., Yagame M., and Suzuki D. J. Nephrol. 19 (2006) 751-757
8. Jay D., Hitomi H., and Griendling K.K. Free. Radic. Biol. Med. 40 (2006) 183-192
9. Pennathur S., and Heinecke J.W. Antioxid. Redox Signal. 9 (2007) 955-969
10. Maiese K., Morhan S.D., and Chong Z.Z. Curr. Neurovasc. Res. 4 (2007) 63-71
11. Paolisso G., Rizzo M.R., Barbieri M., Manzella D., Ragno E., and Maugeri D. Diabetes Metab. 29 (2003) 335-340
12. Grimshaw C.E., Bohren K.M., Lai C.J., and Gabbay K.H. Biochemistry 34 (1995) 14374-14384
13. Greene D.A., Lattimer S.A., and Sima A.A. N. Engl. J. Med. 316 (1987) 599-606
14. Chung S.S., Ho E.C., Lam K.S., and Chung S.K. J. Am. Soc. Nephrol. 14 (2003) S233-S236
15. Drel V.R., Pacher P., Stevens M.J., and Obrosova I.G. Free Radic. Biol. Med. 40 (2006) 1454-1465
16. Palm F. Clin. Exp. Pharmacol. Physiol. 33 (2006) 997-1001
17. Soulis-Liparota T., Cooper M.E., Dunlop M., and Jerums G. Diabetologia 38 (1995) 387-394
18. Srivastava S.K., Ramana K.V., and Bhatnagar A. Endocr. Rev. 26 (2005) 380-392
19. Chung S.S., and Chung S.K. Curr. Drug Targets 6 (2005) 475-486
20. Doggrell S.A. Expert Opin. Investig. Drugs 14 (2005) 683-685
21. Issat T., Jakobisiak M., and Golab J. Oncol. Rep. 16 (2006) 1273-1276
22. Kong W., Wei J., Abidi P., Lin M., Inaba S., Li C., Wang Y., Wang Z., Si S., Pan H., Wang S., Wu J., Wang Y., Li Z., Liu J., and Jiang J.D. Nat. Med. 10 (2004) 1344-1351
23. Leng S.H., Lu F.E., and Xu L.J. Acta Pharmacol. Sin. 25 (2004) 496-502
24. Ni Y.X. Zhong Xi Yi Jie He Za Zhi 8 (1988) 711-713 707
25. Tang L.Q., Wei W., Chen L.M., and Liu S. J. Ethnopharmacol. 108 (2006) 109-115
26. Yin J., Gao Z., Liu D., Liu Z., and Ye J. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E148-E156
27. Hattori T., Furuta K., Nagao T., Nagamatsu T., Ito M., and Suzuki Y. Jpn. J. Pharmacol. 59 (1992) 159-169
28. Marinova E.K., Nikolova D.B., Popova D.N., Gallacher G.B., and Ivanovska N.D. Immunopharmacology 48 (2000) 9-16
29. Nakamura J., Koh N., Sakakibara F., Hamada Y., Hara T., Sasaki H., Chaya S., Komori T., Nakashima E., Naruse K., Kato K., Takeuchi N., Kasuya Y., and Hotta N. J. Pharmacol. Exp. Ther. 287 (1998) 897-902
30. Yin X., Zhang Y., Yu J., Zhang P., Shen J., Qiu J., Wu H., and Zhu X. J. Pharmacol. Sci. 101 (2006) 166-173
31. Hakimoglu F., Kizil G., Kanay Z., Kizil M., and Isi H. Atherosclerosis 192 (2007) 113-122
32. Ohkawa H., Ohishi N., and Yagi K. Anal. Biochem. 95 (1979) 351-358
33. Gilbert R.E., and Cooper M.E. Kidney Int. 56 (1999) 1627-1637
34. Ghahary A., Luo J.M., Gong Y.W., Chakrabarti S., Sima A.A., and Murphy L.J. Diabetes 38 (1989) 1067-1071
35. Kasajima H., Yamagishi S., Sugai S., Yagihashi N., and Yagihashi S. Virchows Arch. 439 (2001) 46-54
36. Isogai S., Inokuchi T., and Ohe K. Diabetes Res. Clin. Pract. 30 (1995) 111-116
37. Donnelly S.M., Zhou X.P., Huang J.T., and Whiteside C.I. Biochem. Cell Biol. 74 (1996) 355-362
38. Dan Q., Wong R.L., Yin S., Chung S.K., Chung S.S., and Lam K.S. Nephron. Exp. Nephrol. 98 (2004) e89-e99
39. Iso K., Tada H., Kuboki K., and Inokuchi T. J. Diabetes Complications 15 (2001) 241-244
40. Tsugawa T., Shinohara R., Nagasaka A., Nakano I., Takeda F., Nagata M., Oda N., Sawai Y., Hayakawa N., Suzuki A., and Itoh M. J. Endocrinol. 181 (2004) 429-435
41. Chang J.M., Kuo M.C., Kuo H.T., Chiu Y.W., and Chen H.C. J. Lab. Clin. Med. 146 (2005) 210-215